A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors

Clinical trial NCT06148636 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06148636
Sponsor: David Bushnell
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Neuroendocrine Tumors Neuroendocrine Tumor of the Lung Neuroendocrine Tumor Grade 1 Neuroendocrine Tumor Grade 2 Neuroendocrine Tumor of Pancreas

Start date: 2023-11-10
Primary completion: 2026-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.